ArticleJournal of managed care & specialty pharmacy2017

Cost-Effectiveness of Pembrolizumab Versus Ipilimumab in Ipilimumab-Naïve Patients with Advanced Melanoma in the United States.

Jingshu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.